ENZIPVIC Trademark

Trademark Overview

On Monday, July 15, 2019, a trademark application was filed for ENZIPVIC with the United States Patent and Trademark Office. The USPTO has given the ENZIPVIC trademark a serial number of 88514725. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 6, 2023. This trademark is owned by Agios Pharmaceuticals, Inc.. The ENZIPVIC trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products for the prevention and treatment of blood disorders; pharmaceutical products for the prevention and treatment of sickle cell disease, PKD and beta thalassemia; pharmaceutical products for the prevention and treatment of rare genetic diseases effecting red blood cells; pharmaceutical products for the prevention and treatment of various anemias
enzipvic

General Information

Serial Number88514725
Word MarkENZIPVIC
Filing DateMonday, July 15, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 6, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 5, 2019

Trademark Statements

Goods and ServicesPharmaceutical products for the prevention and treatment of blood disorders; pharmaceutical products for the prevention and treatment of sickle cell disease, PKD and beta thalassemia; pharmaceutical products for the prevention and treatment of rare genetic diseases effecting red blood cells; pharmaceutical products for the prevention and treatment of various anemias

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, July 19, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAgios Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 021394169
Party NameAgios Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 021394169

Trademark Events

Event DateEvent Description
Monday, February 6, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, February 6, 2023ABANDONMENT - NO USE STATEMENT FILED
Friday, July 8, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 7, 2022SOU EXTENSION 5 GRANTED
Thursday, June 23, 2022SOU EXTENSION 5 FILED
Thursday, July 7, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, June 23, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, February 9, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, February 9, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, February 9, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, February 9, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, February 9, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, December 21, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 17, 2021SOU EXTENSION 4 GRANTED
Friday, December 17, 2021SOU EXTENSION 4 FILED
Friday, December 17, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, June 22, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 18, 2021SOU EXTENSION 3 GRANTED
Friday, June 18, 2021SOU EXTENSION 3 FILED
Friday, June 18, 2021SOU TEAS EXTENSION RECEIVED
Saturday, December 19, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 17, 2020SOU EXTENSION 2 GRANTED
Thursday, December 17, 2020SOU EXTENSION 2 FILED
Thursday, December 17, 2020SOU TEAS EXTENSION RECEIVED
Thursday, June 4, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 2, 2020SOU EXTENSION 1 GRANTED
Tuesday, June 2, 2020SOU EXTENSION 1 FILED
Tuesday, June 2, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, December 31, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 5, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 5, 2019PUBLISHED FOR OPPOSITION
Wednesday, October 16, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 1, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, September 30, 2019ASSIGNED TO EXAMINER
Friday, July 19, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, July 18, 2019NEW APPLICATION ENTERED

Related Keywords

enzipvic pharmaceutical prevention treatment products blood effecting diseases anemias genetic various